Growth Metrics

ReposiTrak (TRAK) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for ReposiTrak (TRAK) over the last 12 years, with Q4 2025 value amounting to $0.09.

  • ReposiTrak's EPS (Weighted Average and Diluted) rose 1250.0% to $0.09 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.37, marking a year-over-year increase of 1562.5%. This contributed to the annual value of $0.35 for FY2025, which is 2101.4% up from last year.
  • As of Q4 2025, ReposiTrak's EPS (Weighted Average and Diluted) stood at $0.09, which was up 1250.0% from $0.09 recorded in Q3 2025.
  • Over the past 5 years, ReposiTrak's EPS (Weighted Average and Diluted) peaked at $0.1 during Q1 2025, and registered a low of $0.03 during Q1 2021.
  • For the 5-year period, ReposiTrak's EPS (Weighted Average and Diluted) averaged around $0.07, with its median value being $0.07 (2023).
  • Within the past 5 years, the most significant YoY rise in ReposiTrak's EPS (Weighted Average and Diluted) was 20776.63% (2021), while the steepest drop was 5000.0% (2021).
  • Over the past 5 years, ReposiTrak's EPS (Weighted Average and Diluted) (Quarter) stood at $0.04 in 2021, then surged by 50.0% to $0.06 in 2022, then increased by 16.67% to $0.07 in 2023, then grew by 14.29% to $0.08 in 2024, then grew by 12.5% to $0.09 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.09 in Q4 2025, compared to $0.09 in Q3 2025 and $0.09 in Q2 2025.